Will a new health council speed the introduction of innovative medicines in the United Kingdom?
Dec 1, 2007
By:Sarah Houlton
One of industry's main complaints is that delaying the introduction of new medicines is a particularly simple way of saving money
 |
In pursuit of innovation, Pharma is increasingly practicing—and attempting to perfect—the science of doing deals. Pharm Exec asked a blue-chip panel of insiders to evaluate how well the experiment is working.
Dec 1, 2007
By:Joanna Breitstein
Science is the lifeblood of pharma, of course. But these days, science isn't just what you produce in your own labs. It's what you can license, buy, partner on, or gain through acquisition. Which means that, increasingly, deals are the lifeblood of pharma.
|
FDAAA aims to restore public trust in drug safety regulation but may curb investment in R&D
Nov 1, 2007
By:Jill Wechsler
FDAAA aims to restore public trust in drug safety regulation but may curb investment in R&D
|
Nov 1, 2007
By:Patrick Clinton
A hospital safety expert says it's now possible to completely eliminate certain adverse events. Pharma can't claim the same yet, but is it time for us to start imagining a time when we can "benchmark perfection"?
|
 | A well-delivered direct mail campaign, with all the bells and whistles, can build a beautiful friendship
Nov 1, 2007
By:Mike Maguire
In this age of new media, social networking, blogs, and cyber-clutter, it's easy to forget the appeal of the real—of things that you can hold in your hand and engage with physically. But make no mistake, despite all of the high-tech tools available to us, advertising still relies on evoking an emotional response by tickling the human senses.
|
 | The best medical education meetings include rock-solid data presented through multiple avenues
Nov 1, 2007
By:Tammy Prouty
Most people exhibit characteristics of both visual and verbal learning styles and learn most effectively when information is presented through a combination of the two
|
We have nothing to fear but the fear of change (with apologies to the wise Franklin D. Roosevelt). But we must get over that if we hope to make a real difference.
Nov 1, 2007
By:Sander A. Flaum
We have nothing to fear but the fear of change (with apologies to the wise Franklin D. Roosevelt). But we must get over that if we hope to make a real difference.
|
Will CROs continue to operate in India, or will Novartis' pullout send them farther East?
Nov 1, 2007
By:Sarah Houlton
Will CROs continue to operate in India, or will Novartis' pullout send them farther East?
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
What's the best managed pharma? Professor Bill Trombetta of Saint Joseph's University attempts to answer the question in Pharm Exec's Industry Audit.
The most respected annual ranking of top 50 pharmaceutical companies by prescription drug sales... Who's in, who's back, and who's out?
Don't miss this Podcast series commemorating the 20th anniversary of HBA's Woman of the Year Award with interviews spanning two decades of change makers.
If you're searching for a new business location, attend the Business Facilities LiveXchange event and learn from location experts, meet with economic developers, and network with peers, all at no cost to you!